5 year survival | 5 year recurrence | 5 year recurrence, ER+/PR± | |||||||
---|---|---|---|---|---|---|---|---|---|
HR | p | N | HR | p | N | HR | p | N | |
TAP | 0.26 (0.08, 0.87) | 0.01 | 264 | 0.35 (0.16, 0.74) | 0.002 | 271 | 0.35 (0.13, 0.92) | 0.02 | 197 |
Hormone therapy | 0.54 (0.25, 1.2) | 0.12 | 262 | 0.68 (0.38, 1.2) | 0.21 | 261 | 1.8 (0.55, 6.2) | 0.28 | 192 |
Chemotherapy | 4.34 (1.63, 11.6) | 0.001 | 262 | 2.51 (1.37, 4.6) | 0.002 | 263 | 2.2 (1, 4.84) | 0.05 | 193 |
Grade | 4.44 (1.74, 11.3) | <0.001 | 230 | 2.3 (1.34, 3.93) | 0.001 | 231 | 2.5 (1.24, 5.05) | 0.007 | 175 |
Stage | 3.35 (1.82, 6.16) | <0.001 | 264 | 2.71 (1.76, 4.17) | <0.001 | 265 | 2.66 (1.47, 4.83) | 0.001 | 195 |
Age | 0.98 (0.95, 1.01) | 0.193 | 264 | 0.98 (0.97, 1) | 0.054 | 265 | 0.97 (0.94, 1) | 0.058 | 195 |
TAP | 0.28 (0.08, 0.95) | 0.04 | 264 | 0.38 (0.18, 0.81) | 0.012 | 265 | 0.37 (0.14, 0.98) | 0.045 | 195 |
Stage | 3.25 (1.76, 6) | <0.001 | 2.63 (1.71, 4.06) | <0.001 | 2.57 (1.41, 4.69) | 0.002 | |||
TAP | 0.55 (0.16, 1.93) | 0.35 | 230 | 0.54 (0.23, 1.24) | 0.15 | 231 | 0.51 (0.19, 1.39) | 0.19 | 174 |
Grade | 3.93 (1.52, 10.18) | 0.005 | 2.05 (1.19, 3.52) | 0.01 | 2.3 (1.15, 4.59) | 0.018 | |||
TAP | 0.28 (0.08, 0.94) | 0.039 | 264 | 0.38 (0.18, 0.82) | 0.014 | 265 | 0.37 (0.14, 0.98) | 0.045 | 195 |
Age | 0.99 (0.96, 1.02) | 0.37 | 0.98 (0.96, 1.01) | 0.16 | 0.97 (0.94, 1.01) | 0.097 | |||
TAP | 0.27 (0.08, 0.90) | 0.032 | 262 | 0.37 (0.17, 0.78) | 0.0093 | 261 | 0.35 (0.13,0.93) | 0.036 | 192 |
Hormone therapy | 0.58 (0.27, 1.3) | 0.17 | 0.73 (0.41, 1.3) | 0.3 | 1.77 (0.53, 5.9) | 0.35 | |||
TAP | 0.34 (0.1, 1.14) | 0.081 | 262 | 0.42 (0.2, 0.91) | 0.027 | 263 | 0.38 (0.14, 1.01) | 0.052 | 193 |
Chemotherapy | 3.69 (1.37, 9.92) | 0.01 | 2.16 (1.17, 4.01) | 0.014 | 1.94 (0.87, 4.3) | 0.1 | |||
TAP | 0.33 (0.1, 1.13) | 0.078 | 262 | 0.41 (0.19, 0.89) | 0.023 | 263 | 0.38 (0.14, 1.03) | 0.057 | 193 |
Stage | 2.77 (1.42, 5.4) | 0.003 | 2.44 (1.53, 3.9) | 0 | 2.42 (1.27, 4.61) | 0.007 | |||
Chemotherapy | 2.21 (0.79, 6.17) | 0.13 | 1.35 (0.7, 2.59) | 0.37 | 1.23 (0.53, 2.85) | 0.63 | |||
TAP | 0.32 (0.1, 1.1) | 0.07 | 262 | 0.41 (0.19, 0.89) | 0.024 | 263 | 0.39 (0.15, 1.06) | 0.065 | 193 |
Stage | 2.8 (1.43, 5.47) | 0.003 | 2.44 (1.53, 3.9) | 0 | 2.53 (1.34, 4.76) | 0.004 | |||
Chemotherapy | 2.98 (0.89, 10) | 0.077 | 1.34 (0.61, 2.94) | 0.47 | 0.85 (0.31, 2.32) | 0.75 | |||
Age | 1.02 (0.98, 1.06) | 0.35 | 1 (0.97, 1.03) | 0.98 | 0.97 (0.94, 1.01) | 0.19 |